Should FDA Drug Safety Alerts Go To Professionals First?
Physicians need to know about drug safety problems before their patients hear about them, Steven Schachter, president of the American Epilepsy Society, told the FDA Transparency Task Force June 24
You may also be interested in...
FDA should explain the why of its important regulatory decisions in consumer-friendly language, according to the Pharmaceutical Research and Manufacturers of America
FDA's formation of an internal "Transparency Task Force" is a savvy approach that allows agency leaders to begin making good now on their pledges to enhance openness while giving them six months to decide whether to release any specific new information
A class-wide relabeling is expected, but Pfizer says that Neurontin and Lyrica show no signs of increased events.